{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:15:02Z","timestamp":1740147302046,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Glycated hemoglobin is a well-known marker for evaluating long-term glycemic control. However, the accuracy of glycated hemoglobin measurement can be affected by the presence of hemoglobin variants, which makes the determination and interpretation of glycated hemoglobin values in terms of glycemic control not only difficult but also misleading. Here we present the first ever case of a patient with type 2 diabetes with hemoglobin E from Nepal, diagnosed incidentally because of spurious glycated hemoglobin levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 45-year-old Hindu Mongolian female with a history of type 2 diabetes for around 9\u00a0years but not very compliant with follow-ups was referred to our facility for plasma fasting and postprandial blood glucose levels and glycated hemoglobin. Fasting and postprandial blood sugars were found to be high. A consistent very low glycated hemoglobin by two different high-performance liquid chromatography (HPLC) methods compelled us to call the patient for a detailed clinical history and for the records of investigations done in the past. The patient has been a known case of type 2 diabetes for around 9\u00a0years and presented irregularly for follow-up visits. Around 4\u00a0years ago, she presented to a healthcare facility with fatigue, severe headaches, pain in the abdomen, discomfort, and dizziness for a couple of months, where she was shown to have high blood glucose. She was referred to a tertiary-level hospital in Kathmandu, where she was prescribed metformin 500\u00a0mg once daily (OD). Due to her abnormal hemoglobin A1c reports, she was then sent to the National Public Health Laboratory for repeat investigations. Her blood and urine investigations were sent. Complete blood count findings revealed high red blood cell and white blood cell counts, a low mean corpuscular volume, and a high red cell distribution width-coefficient of variation. Other parameters, including serum electrolytes, renal function tests, liver function tests, and urine routine examinations, were within normal limits. A peripheral blood smear revealed microcytic hypochromic red cells with some target cells. Hemoglobin electrophoresis showed a very high percentage of hemoglobin E, a very low percentage of hemoglobin A2, and normal proportions of hemoglobin A and hemoglobin F. A diagnosis of homozygous hemoglobin E was made, and family screening was advised.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Clinicians should be aware of the limitations of glycated hemoglobin estimation by ion exchange high-performance liquid chromatography in patients with hemoglobin E and other hemoglobin variants. If the clinical impression and glycated hemoglobin test results do not match, glycated hemoglobin values should be determined with a second method based on a different principle, and glycemic status should be confirmed through alternative investigations, preferably those that are not influenced by the presence of hemoglobin variants (for example, boronate affinity chromatography, fructosamine test, glycated albumin test, the oral glucose tolerance test, continuous glucose monitoring, etc.). Consistent or even doubtful results should also raise the suspicion of a hemoglobin variant, which should be confirmed through further evaluation and investigations.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-024-04518-y","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:01:51Z","timestamp":1718409711000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An incidental finding of a hemoglobin E variant in a diabetic patient with an abnormal glycated hemoglobin level: a case report"],"prefix":"10.1186","volume":"18","author":[{"given":"Rashmi","family":"Karki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0748-0767","authenticated-orcid":false,"given":"Samir","family":"Lamichhane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runa","family":"Jha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rekha","family":"Manandhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,15]]},"reference":[{"key":"4518_CR1","unstructured":"Abbreviated Report of a WHO Consultation. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. 2011."},{"issue":"1","key":"4518_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/jclinpath-2017-204755","volume":"72","author":"L Campbell","year":"2019","unstructured":"Campbell L, Pepper T, Shipman K. HbA1c: a review of non-glycaemic variables. J Clin Pathol. 2019;72(1):12\u20139.","journal-title":"J Clin Pathol"},{"issue":"9131","key":"4518_CR3","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837\u201353.","journal-title":"Lancet"},{"issue":"1","key":"4518_CR4","doi-asserted-by":"publisher","first-page":"12419","DOI":"10.1038\/s41598-018-29998-z","volume":"8","author":"WY Lim","year":"2018","unstructured":"Lim WY, et\u00a0al. Screening for diabetes with HbA1c: test performance of HbA1c compared to fasting plasma glucose among Chinese, Malay and Indian community residents in Singapore. Sci Rep. 2018;8(1):12419.","journal-title":"Sci Rep"},{"issue":"2","key":"4518_CR5","first-page":"13","volume":"9","author":"SI Nureslyna","year":"2013","unstructured":"Nureslyna SI, et\u00a0al. Percentage of haemoglobin variants detected during HbA1c analysis in hospital Kuala Lumpur. Malays J Med Health Sci. 2013;9(2):13\u20137.","journal-title":"Malays J Med Health Sci"},{"issue":"3","key":"4518_CR6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2337\/diacare.23.3.339","volume":"23","author":"WJ Schnedl","year":"2000","unstructured":"Schnedl WJ, et\u00a0al. Evaluation of HbA1c determination methods in patients with hemoglobinopathies. Diabetes Care. 2000;23(3):339\u201344.","journal-title":"Diabetes Care"},{"issue":"6","key":"4518_CR7","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3892\/etm.2022.11643","volume":"24","author":"Z Chen","year":"2022","unstructured":"Chen Z, et\u00a0al. Interpretation of HbA1c lies at the intersection of analytical methodology, clinical biochemistry and hematology (review). Exp Ther Med. 2022;24(6):707.","journal-title":"Exp Ther Med"},{"issue":"4","key":"4518_CR8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/1753-0407.12624","volume":"10","author":"Z Bloomgarden","year":"2018","unstructured":"Bloomgarden Z, Handelsman Y. How does CKD affect HbA1c? J Diabetes. 2018;10(4):270.","journal-title":"J Diabetes"},{"issue":"1","key":"4518_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s13300-017-0362-4","volume":"9","author":"T Sehrawat","year":"2018","unstructured":"Sehrawat T, et\u00a0al. Utility and limitations of glycated hemoglobin (HbA1c) in patients with liver cirrhosis as compared with oral glucose tolerance test for diagnosis of diabetes. Diabetes Ther. 2018;9(1):243\u201351.","journal-title":"Diabetes Ther"},{"issue":"2","key":"4518_CR10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/ard.42.2.238-b","volume":"42","author":"D Lewis","year":"1983","unstructured":"Lewis D, et\u00a0al. Glycosylated haemoglobin in rheumatoid arthritis. Ann Rheum Dis. 1983;42(2):238\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4518_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1309\/AJCPQ23GTTMLAEVL","volume":"141","author":"JM Rhea","year":"2014","unstructured":"Rhea JM, Molinaro R. Pathology consultation on HbA(1c) methods and interferences. Am J Clin Pathol. 2014;141(1):5\u201316.","journal-title":"Am J Clin Pathol"},{"key":"4518_CR12","unstructured":"Bachir D, Galacteros F. Hemoglobin E disease. Orphanet Encyclopedia. 2004."},{"key":"4518_CR13","unstructured":"Braunstein EM. Hemoglobin E disease. Merck Manual. 2017."},{"issue":"8","key":"4518_CR14","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a011734","volume":"2","author":"S Fucharoen","year":"2012","unstructured":"Fucharoen S, Weatherall DJ. The hemoglobin E thalassemias. Cold Spring Harb Perspect Med. 2012;2(8): a011734.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"10","key":"4518_CR15","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/clinchem\/43.10.1811","volume":"43","author":"JH Eckfeldt","year":"1997","unstructured":"Eckfeldt JH, Bruns DE. Another step toward standardization of methods for measuring hemoglobin A1c. Clin Chem. 1997;43(10):1811\u20133.","journal-title":"Clin Chem"},{"issue":"3","key":"4518_CR16","first-page":"352","volume":"55","author":"M Musalmah","year":"2000","unstructured":"Musalmah M, et\u00a0al. Effect of hemoglobin E on glycosylated hemoglobin determinations using different commercial kits. Med J Malaysia. 2000;55(3):352\u20136.","journal-title":"Med J Malaysia"},{"issue":"6","key":"4518_CR17","first-page":"438","volume":"94","author":"Y Chen","year":"2014","unstructured":"Chen Y, et\u00a0al. Influence and analysis of seven kinds of hemoglobin variants on HbA1c detection. Zhonghua Yixue Zazhi. 2014;94(6):438\u201341.","journal-title":"Zhonghua Yixue Zazhi"},{"issue":"3","key":"4518_CR18","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1177\/193229680900300307","volume":"3","author":"RR Little","year":"2009","unstructured":"Little RR, Roberts WL. A review of variant hemoglobins interfering with hemoglobin A1c measurement. J Diabetes Sci Technol. 2009;3(3):446\u201351.","journal-title":"J Diabetes Sci Technol"},{"issue":"3","key":"4518_CR19","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1016\/j.diabres.2008.11.021","volume":"83","author":"K Paisooksantivatana","year":"2009","unstructured":"Paisooksantivatana K, et\u00a0al. Influence of hemoglobin E on measurement of hemoglobin A1c by immunoassays. Diabetes Res Clin Pract. 2009;83(3):e84\u20135.","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"4518_CR20","first-page":"297","volume":"67","author":"M Guadalupe Vargas","year":"2020","unstructured":"Guadalupe Vargas M, et\u00a0al. Assessment of two glycated hemoglobin immunoassays. Endocrinol Diabetes Nutr (Engl Ed). 2020;67(5):297\u2013303.","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"issue":"4","key":"4518_CR21","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/clinchem\/39.4.663","volume":"39","author":"WG John","year":"1993","unstructured":"John WG, et\u00a0al. Enzyme immunoassay\u2014a new technique for estimating hemoglobin A1c. Clin Chem. 1993;39(4):663\u20136.","journal-title":"Clin Chem"},{"issue":"7","key":"4518_CR22","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1093\/clinchem\/44.7.1562","volume":"44","author":"T Watanabe","year":"1998","unstructured":"Watanabe T, et\u00a0al. A nondiabetic case of hemoglobin variant (Hb Niigata) with inappropriately high and low HbA1c titers detected by different methods. Clin Chem. 1998;44(7):1562\u20134.","journal-title":"Clin Chem"},{"issue":"8","key":"4518_CR23","first-page":"704","volume":"79","author":"DJ Weatherall","year":"2001","unstructured":"Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79(8):704\u201312.","journal-title":"Bull World Health Organ"},{"issue":"3","key":"4518_CR24","first-page":"455","volume":"47","author":"AI Chernoff","year":"1956","unstructured":"Chernoff AI, et\u00a0al. Studies on hemoglobin E. I. The clinical, hematologic, and genetic characteristics of the hemoglobin E syndromes. J Lab Clin Med. 1956;47(3):455\u201389.","journal-title":"J Lab Clin Med."},{"issue":"1","key":"4518_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/blood.V9.1.1.1","volume":"9","author":"V Minnich","year":"1954","unstructured":"Minnich V, et\u00a0al. Mediterranean anemia: a study of thirty-two cases in Thailand. Blood. 1954;9(1):1\u201323.","journal-title":"Blood"},{"issue":"5","key":"4518_CR26","doi-asserted-by":"publisher","first-page":"683","DOI":"10.4103\/2230-8210.163211","volume":"19","author":"N Yedla","year":"2015","unstructured":"Yedla N, Kuchay MS, Mithal A. Hemoglobin E disease and glycosylated hemoglobin. Indian J Endocrinol Metab. 2015;19(5):683\u20135.","journal-title":"Indian J Endocrinol Metab"},{"issue":"4","key":"4518_CR27","first-page":"522","volume":"134","author":"NF Olivieri","year":"2011","unstructured":"Olivieri NF, Pakbaz Z, Vichinsky E. Hb E\/beta-thalassaemia: a common and clinically diverse disorder. Indian J Med Res. 2011;134(4):522\u201331.","journal-title":"Indian J Med Res"},{"issue":"1","key":"4518_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2174\/1573399811666150701143112","volume":"12","author":"RT Ribeiro","year":"2016","unstructured":"Ribeiro RT, Macedo MP, Raposo JF. HbA1c, fructosamine, and glycated albumin in the detection of dysglycaemic conditions. Curr Diabetes Rev. 2016;12(1):14\u20139.","journal-title":"Curr Diabetes Rev"},{"key":"4518_CR29","unstructured":"Mahabeer S. HbA1c measurement and assay interferences. Pathologists Lancet Laboratories, newsletter; 4th quarter. 2018."},{"issue":"3","key":"4518_CR30","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1590\/2359-3997000000272","volume":"61","author":"PAC Freitas","year":"2017","unstructured":"Freitas PAC, Ehlert LR, Camargo JL. Glycated albumin: a potential biomarker in diabetes. Arch Endocrinol Metab. 2017;61(3):296\u2013304.","journal-title":"Arch Endocrinol Metab"},{"issue":"9495","key":"4518_CR31","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(05)67396-5","volume":"366","author":"A Premawardhena","year":"2005","unstructured":"Premawardhena A, et\u00a0al. Haemoglobin E beta thalassaemia in Sri Lanka. Lancet. 2005;366(9495):1467\u201370.","journal-title":"Lancet"},{"issue":"6","key":"4518_CR32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3126\/ajms.v13i6.43044","volume":"13","author":"S Roy","year":"2022","unstructured":"Roy S, et\u00a0al. Prevalence of hemoglobin variants and their effect on Hba1c measurement among the indigenous population of north Bengal attending a tertiary care hospital. Asian J Med Sci. 2022;13(6):90\u20135.","journal-title":"Asian J Med Sci"},{"issue":"1","key":"4518_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s13256-017-1377-1","volume":"11","author":"V Guedes","year":"2017","unstructured":"Guedes V, et\u00a0al. Hemoglobin Himeji and inconsistent hemoglobin A1c values: a case report. J Med Case Rep. 2017;11(1):201.","journal-title":"J Med Case Rep"},{"issue":"4","key":"4518_CR34","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2022.14","volume":"37","author":"W Wan Nik","year":"2022","unstructured":"Wan Nik W, et\u00a0al. Significantly high HbA(1c) in diabetic patient with Hb J: Case Report. Oman Med J. 2022;37(4): e393.","journal-title":"Oman Med J"},{"issue":"2","key":"4518_CR35","first-page":"43","volume":"9","author":"M Mitchai","year":"2021","unstructured":"Mitchai M, et\u00a0al. Misleading HbA1c measurement in diabetic patients with hemoglobin variants. Med Sci (Basel). 2021;9(2):43.","journal-title":"Med Sci (Basel)"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-024-04518-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-024-04518-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-024-04518-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:02:13Z","timestamp":1718409733000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-024-04518-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,15]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4518"],"URL":"https:\/\/doi.org\/10.1186\/s13256-024-04518-y","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2024,6,15]]},"assertion":[{"value":"6 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval from the institutional review board (IRB) has not been sought. Written informed consent was obtained from the patient for participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"279"}}